-transparent.png){kind=logo}
Chronic pulmonary lymphoid hyperplasia occurs alone or is associated with a variety of disorders of the immune system. It may be a diffuse or localized process and has been referred to as lymphoid interstitial pneumonitis or pseudolymphoma, respectively. Chronic lymphoid hyperplasia in other organs has been followed by the development of malignant lymphoma, particularly when associated with disorders of the immune system. This report describes two patients with chronic hyperplasia of the pulmonary interstitial lymphoid tissue who had malignant lymphoma, immunoblastic type found at autopsy. Long-term steroid usage in one patient suggests the possibility that immunosuppressive therapy may increase the risk of developing malignant lymphoma in patients with chronic pulmonary lymphoid hyperplasia.
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
September 2012,
World journal of surgical oncology,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
January 1986,
Acta haematologica,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
March 2018,
Histopathology,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
August 2020,
Pediatric hematology and oncology,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
January 1995,
Annales de dermatologie et de venereologie,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
October 1976,
Lancet (London, England),
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
August 2009,
Hematology/oncology clinics of North America,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
September 2019,
Archives of pathology & laboratory medicine,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
November 1987,
Archives of pathology & laboratory medicine,
R L Kradin, and
R H Young, and
L A Kradin, and
E J Mark
August 1979,
Lancet (London, England),
